# Safety and Effectiveness Evaluation of Two Kinds of Peritoneal Dialysate

Study · id `cardio:ct-nct01779557` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01779557](<https://clinicaltrials.gov/study/NCT01779557>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01779557

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 750 participants.

## Technical summary

Registry record NCT01779557. Randomized; single masking; primary purpose treatment. Start 2013-02 (actual); primary completion 2019-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 750 participants (enrolled count; ClinicalTrials.gov record NCT01779557, source copy `cardio:ctgov-nct01779557-2022-03-10`, retrieved 2026-10-26)
- Started: 2013-02 (actual) (ClinicalTrials.gov record NCT01779557, source copy `cardio:ctgov-nct01779557-2022-03-10`, retrieved 2026-10-26)
- Primary completion: 2019-10 (actual) (ClinicalTrials.gov record NCT01779557, source copy `cardio:ctgov-nct01779557-2022-03-10`, retrieved 2026-10-26)
- Completion: 2021-09 (actual) (ClinicalTrials.gov record NCT01779557, source copy `cardio:ctgov-nct01779557-2022-03-10`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01779557, source copy `cardio:ctgov-nct01779557-2022-03-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01779557-2022-03-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Effectiveness Evaluation of Two Kinds of Peritoneal Dialysate
- Acronym: SEED
- Condition: Kidney Failure,Chronic
- Intervention (Drug): Huaren Peritoneal Dialysate
- Intervention (Drug): Baxter Peritoneal Dialysate
- Lead sponsor: Chinese PLA General Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Chinese PLA General Hospital (`cardio:org-chinese-pla-general-hospital`)

## Provenance

Content hash: eed8b7f8c322e91faa8305183b607ba4e52d6264092e1ae8e68a240e180bd0be
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
